A Study of Valacyclovir as Treatment for Genital Herpes Simplex Virus in HIV-Infected Patients
Public ClinicalTrials.gov record NCT00005663. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An International, Randomized, Double-Blind, Placebo-Controlled Study of Valacyclovir for the Suppression of Recurrent Ano-Genital HSV Infections in HIV-Infected Subjects
Study identification
- NCT ID
- NCT00005663
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Glaxo Wellcome
- Industry
- Enrollment
- Not listed
Conditions and interventions
Conditions
Interventions
- Valacyclovir hydrochloride Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 1999
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Jun 23, 2005
Started 1999
United States locations
- U.S. sites
- 20
- U.S. states
- 12
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| East Bay AIDS Ctr | Berkeley | California | 94705 | — |
| Pacific Oaks Research | Beverly Hills | California | 90211 | — |
| Kraus Med Partners | Los Angeles | California | 90036 | — |
| ViRx Inc | San Francisco | California | 94109 | — |
| IDC Research Initiative | Altamonte Springs | Florida | 32701 | — |
| Healthnet Institute | Fort Lauderdale | Florida | 33316 | — |
| Univ of Miami School of Medicine | Miami | Florida | 331361013 | — |
| Treasure Coast Infectious Disease Consultants | Vero Beach | Florida | 32960 | — |
| Palm Beach Research Ctr | West Palm Beach | Florida | 33409 | — |
| Indiana Univ School of Medicine / Dept of Infect Dis | Indianapolis | Indiana | 46202 | — |
| Univ of Minnesota | Minneapolis | Minnesota | 55455 | — |
| Advanced Biomedical Research Inc | Hackensack | New Jersey | 07601 | — |
| Nalle Clinic / Clinical Research Dept | Charlotte | North Carolina | 28207 | — |
| Wake County Dept of Health | Raleigh | North Carolina | 27610 | — |
| Westover Heights Clinic | Portland | Oregon | 97210 | — |
| Philadelphia FIGHT | Philadelphia | Pennsylvania | 19107 | — |
| Dr Alvan Fisher | Providence | Rhode Island | 02907 | — |
| Baylor College of Medicine / Dept of Medicine | Houston | Texas | 770303498 | — |
| Richmond AIDS Consortium | Richmond | Virginia | 23219 | — |
| Univ of Washington Virology Research Clinic | Seattle | Washington | 98122 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00005663, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 23, 2005 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00005663 live on ClinicalTrials.gov.